Dmitry Balyasny’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Dmitry Balyasny’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-78,400	Closed	-$3.01M	–	2878
2023 Q2	$3.01M	Buy	+78,400	New	+$2.01M	0.01%	1236

Dmitry Balyasny's KDNY Position: Q3 2023 in Review

Dmitry Balyasny sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 605,294 shares — an estimated $23.3M sold.

Dmitry Balyasny first reported a position in KDNY in Q1 2017 and held it in 6 quarters. The position peaked at $23.3M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Dmitry Balyasny reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Dmitry Balyasny sold 605,294 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $23.3M.
Dmitry Balyasny first reported a position in Chinook Therapeutics, Inc. Common Stock in Q1 2017 and held it in 6 quarters.
Dmitry Balyasny's Chinook Therapeutics, Inc. Common Stock position peaked at $23.3M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.